
Understanding documentation, accuracy and compliance
Todd Shryock is managing editor of Medical Economics.

Understanding documentation, accuracy and compliance

Nephrodite's Holly system advances kidney care with an implantable continuous dialysis solution, enhancing patient freedom and quality of life.

Ruthless Spine expands its RJB angle measurement instrument to Israel, enhancing surgical precision and patient care in spine surgery.

Flow Neuroscience's FDA-approved device offers an at-home treatment for depression, providing a non-drug option with proven effectiveness and minimal side effects.


Bendit Technologies launches the Bendit17 Microcatheter, enhancing precision in vascular procedures with FDA clearance for U.S. market entry.

Pulse Biosciences partners with MD Anderson to explore nonthermal ablation technology for treating thyroid cancer, promising less invasive options.

SS Innovations is advancing surgical robotics with the SSi Mantra, aiming for FDA clearance to enhance affordability and accessibility in U.S. health care.

CONMED says it is shifting focus from gastroenterology to core surgical innovations to enhance growth and profitability while winding down key distribution agreements.


ViaLase launching a trial for incision-free glaucoma treatment, aiming to redefine IOP management with innovative, safer solutions.

Todd's background in scaling advanced robotic platforms, building global engineering teams, and driving innovation in endoscopy and minimally invasive surgery will support Swan’s push to commercialize a flexible endoluminal surgical robotics platform.

Being successful with in-office rapid testing requires a careful look at your patient population, staffing, and workflows

Blood-based diagnostic aims to reduce unnecessary prostate biopsies and improve cancer risk assessment.

Switching to value-based care also means changing how you code and how you approach patient care

New federal loan limits in the OBBBA threaten to increase medical school debt and worsen physician shortages, impacting diversity in health care.

GE Healthcare launches Pristina Recon DL, a new AI-driven mammography technology enhancing image quality and supporting early breast cancer detection.

The growing trend toward device-based metabolic interventions

Effort will prioritize technologies with strong clinical and commercial potential.

Transmural Systems launches TELLTALE, an innovative electrosurgical guidewire, enhancing safety in transcatheter aortic valve replacement procedures.

The growing trend toward device-based metabolic interventions

Deal is expected to accelerate innovation in cancer diagnostics and expand access to early detection tools at a time when global cancer rates continue to climb

GE HealthCare expects the deal to be completed early next year and immediately contribute to its bottomline.

Mindray's TE Air e5M ultrasound machine advances imaging with wireless technology, offering affordability, portability, and features for diverse clinical settings.


The growing trend toward device-based metabolic interventions

Dexcom Smart Basal optimizes insulin dosing for Type 2 diabetes, integrating CGM data for personalized recommendations and enhancing patient care efficiency.

Does it matter what technology tools a health care employer has?

TriSalus unveils the TriNav XP Infusion System, enhancing drug delivery for solid tumors with advanced embolic particle capabilities and improved navigation.

BrainsWay's FDA-approved Deep TMS system offers new hope for adolescents with depression, enhancing access to effective noninvasive treatment options.